Europe’s biotech industry is more buoyant now than it’s ever been.
A combination of eager investors, the high-speed development of COVID-19 vaccines, exciting scientific developments and last year’s acceleration of existing trends is driving the sector to new heights. And as part of one of the world’s largest life science technology clusters in the so-called Golden Triangle with Oxford and Cambridge, London is riding that wave.